327 related articles for article (PubMed ID: 29789581)
1. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
[TBL] [Abstract][Full Text] [Related]
2. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
[TBL] [Abstract][Full Text] [Related]
3. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
4. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS.
Harley J; Hagemann C; Serio A; Patani R
Brain; 2020 Dec; 143(12):e103. PubMed ID: 33253377
[No Abstract] [Full Text] [Related]
5. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
Lenzi J; De Santis R; de Turris V; Morlando M; Laneve P; Calvo A; Caliendo V; Chiò A; Rosa A; Bozzoni I
Dis Model Mech; 2015 Jul; 8(7):755-66. PubMed ID: 26035390
[TBL] [Abstract][Full Text] [Related]
6. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.
Humphrey J; Birsa N; Milioto C; McLaughlin M; Ule AM; Robaldo D; Eberle AB; Kräuchi R; Bentham M; Brown AL; Jarvis S; Bodo C; Garone MG; Devoy A; Soraru G; Rosa A; Bozzoni I; Fisher EMC; Mühlemann O; Schiavo G; Ruepp MD; Isaacs AM; Plagnol V; Fratta P
Nucleic Acids Res; 2020 Jul; 48(12):6889-6905. PubMed ID: 32479602
[TBL] [Abstract][Full Text] [Related]
7. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
8. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis.
Tyzack GE; Neeves J; Crerar H; Klein P; Ziff O; Taha DM; Luisier R; Luscombe NM; Patani R
Brain; 2021 Aug; 144(7):1985-1993. PubMed ID: 33693641
[TBL] [Abstract][Full Text] [Related]
10. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.
Hall CE; Yao Z; Choi M; Tyzack GE; Serio A; Luisier R; Harley J; Preza E; Arber C; Crisp SJ; Watson PMD; Kullmann DM; Abramov AY; Wray S; Burley R; Loh SHY; Martins LM; Stevens MM; Luscombe NM; Sibley CR; Lakatos A; Ule J; Gandhi S; Patani R
Cell Rep; 2017 May; 19(9):1739-1749. PubMed ID: 28564594
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
[TBL] [Abstract][Full Text] [Related]
12. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
13. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
[TBL] [Abstract][Full Text] [Related]
14. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
15. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis.
Dodge JC; Yu J; Sardi SP; Shihabuddin LS
Sci Rep; 2021 Jan; 11(1):803. PubMed ID: 33436868
[TBL] [Abstract][Full Text] [Related]
16. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
17. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
[TBL] [Abstract][Full Text] [Related]
18. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
19. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.
Vandoorne T; Veys K; Guo W; Sicart A; Vints K; Swijsen A; Moisse M; Eelen G; Gounko NV; Fumagalli L; Fazal R; Germeys C; Quaegebeur A; Fendt SM; Carmeliet P; Verfaillie C; Van Damme P; Ghesquière B; De Bock K; Van Den Bosch L
Nat Commun; 2019 Sep; 10(1):4147. PubMed ID: 31515480
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis.
Hogan AL; Grima N; Fifita JA; McCann EP; Heng B; Fat SCM; Wu S; Maharjan R; Cain AK; Henden L; Rayner S; Tarr I; Zhang KY; Zhao Q; Zhang ZH; Wright A; Lee A; Morsch M; Yang S; Williams KL; Blair IP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):990-1003. PubMed ID: 34288034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
